A: The Commission's independence rules apply to audits of financial statements required by SEC rules, except for those required by Rule 3-05 and 3-14 of Regulation S-X and Item 310(c) and (e) of Regulation S-B.
1 The Centers for Disease Control and Prevention (CDC) recommends 2 doses of quadrivalent meningococcal conjugate vaccine for adolescents 11 through 18 years of age.  The first dose should be given at 11 or 12 years of age, followed by a booster dose at age 16.
Make sure your preteen and teen get the meningococcal conjugate vaccine for protection against meningococcal disease, a very serious illness where death can occur in as little as a few hours. The meningococcal conjugate vaccine is recommended at 11-12 years of age and a booster dose at age 16.Meningococcal disease is not very common in the United States, but can be devastating and oftenâand unexpectedlyâstrikes otherwise healthy people.eningococcal conjugate vaccine is routinely recommended for all 11 through 18 year olds. Preteens should get the first dose of this vaccine at their 11â12 year old check-up. Teenagers are recommended to get a booster dose at age 16. If your teenager missed getting a dose, ask the doctor about getting it now.